Omkar Pharmachem share news, announcements and annual reports
BSE: 532167Chemicals & PetrochemicalsSmall Cap
Omkar Pharmachem Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 1997
Last close ₹6.25₹0.00 (0.00%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹6.25.
30 Oct: open ₹6.25, high ₹6.25, low ₹6.25
52-week range of traded prices to 30 Oct 2026
₹6.25Low, 29 Oct 2026₹29.74High, 15 Dec 2025
- Under BSE's graded surveillance, stage II, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹6.30 Cr3,900th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 73.98
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.17
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 0.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 0.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 25
Omkar Pharmachem results
91 filed, newest first. Page 2 of 2.
Nov 2018
Oct 2018
1 Oct · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Aug 2018
May 2018
Mar 2018
Feb 2018
Dec 2017
Sep 2017
29 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
May 2017
Feb 2017
Nov 2016
Oct 2016
Aug 2016
May 2016
Feb 2016
Nov 2015
Oct 2015
Aug 2015
Jun 2015
Feb 2015
Nov 2014
Aug 2014
Jun 2014
Jan 2014
31 Jan · Results
Nov 2013
6 Nov · Results
Aug 2013
14 Aug · Results
Jun 2013
Jan 2013
31 Jan · Results
Nov 2012
6 Nov · Results
Aug 2012
14 Aug · Results
Jun 2012
12 Jun · Results
Feb 2012
8 Feb · Results
Oct 2011
31 Oct · Results
Aug 2011
16 Aug · Results
May 2011
31 May · Results
Jan 2011
31 Jan · Results
Oct 2010
30 Oct · Results
Financial Results for the Quarter ended September 30, 2010.
Aug 2010
5 Aug · Results
Jun 2010
15 Jun · Results
Feb 2010
9 Feb · Results